P-selectin expression on platelets determines size and stability of platelet aggregates

Circulation

Volumn 102, Issue 16, 2000, Pages 1931-1936

  Merten, Michael ^a   Thiagarajan, Perumal ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Fibrinogen; Glycoproteins; Platelet derived factors

Indexed keywords

ABCIXIMAB; EDETATE CALCIUM; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IB; LECTIN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PADGEM PROTEIN ANTIBODY; PROTEIN PSGL 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; THROMBOCYTE AGGREGATION; THROMBOCYTE LIFESPAN; THROMBOCYTE SHAPE; THROMBOCYTE STRUCTURE;

EID: 0034680348     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.16.1931     Document Type: Article

References (40)

1. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation: Characterization and subcellular localization of platelet activation-dependent/granule-external membrane protein
2. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies
3. A platelet membrane protein expressed during platelet activation and secretion: Studies using a monoclonal antibody specific for thrombin-activated platelets
4. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin
5. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140
6. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
7. Mechanisms involved in platelet vessel wall interaction
8. Regulation of platelet aggregation by post-fibrinogen binding events: Insights provided by dithiothreitol-treated platelets
9. Stabilization of platelet-fibrinogen interactions: Modulation by divalent cations
10. Factors influencing the deaggregation of human and rabbit platelets
11. Factors influencing the deaggregation of chymotrypsin-treated human platelets aggregated by fibrinogen
12. Fibrinogen-independent aggregation and deaggregation of human platelets: Studies in two afibrinogenemic patients
13. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism
14. Platelet aggregates as markers of platelet activation: Characterization of flow cytometric method suitable for clinical applications
15. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry, I: Methodology, theory and results for two distinct activators
16. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
17. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen
18. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation
19. Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: Use of human-mouse chimaera and homologue-replacement mutagenesis
20. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin
21. Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-1 on leukocytes
22. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin
23. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1
24. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin
25. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation
26. Selectin ligands
27. Characterization of a specific ligand for P-selection on myeloid cells: A minor glycoprotein with sialylated O-linked oligosaccharides
28. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions In vivo
29. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen
30. Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins
31. The effect of thrombin on the organization of human platelet membrane glycosphingolipids: The sphingosine composition of platelet glycolipids and ceramides
32. Ganglioside content of human platelets: Differences in resting and activated platelets
33. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow
34. Alpha IIb beta 3 redistribution triggered by receptor cross-linking
35. Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: An immunogold-surface replica study
36. Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM)
37. Thrombin-induced platelet aggregation is mediated by a platelet plasma membrane-bound lectin
38. Expression of thrombin-enhanced platelet lectin activity is controlled by secretion
39. Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis
40. Adhesive interaction between P-selectin and sialyl Lewis(x) plays an important role in recurrent coronary arterial thrombosis in dogs